Abstract:Schizophrenia is a severe neuropsychiatric disorder with core features including hallucinations, delusions, and cognition deficits. Accumulating evidence has implicated abnormal DNA methylation in the development of schizophrenia. However, the mechanisms by which DNA methylation changes alter the risk for schizophrenia remain largely unknown. We recently carried out a DNA methylome study of peripheral blood samples from 469 first-episode patients with schizophrenia and 476 age- and gender-matched healthy controls of Han Chinese origin. Genomic DNA methylation patterns were quantified using an Illumina Infinium Human MethylationEPIC BeadChip. We identified multiple differentially methylated positions (DMPs) and regions between patients and controls. The most significant DMPs were annotated to genes C17orf53, THAP1 and KCNQ4 (KV7.4), with Bonferroni-adjusted P values of ({mathrm{1}}{mathrm{.34}} imes {mathrm{10}}^{{mathrm{ - 12}}}), ({mathrm{1}}{mathrm{.15}} imes {mathrm{10}}^{{mathrm{ - 11}}}), and ({mathrm{3}}{mathrm{.11}} imes {mathrm{10}}^{{mathrm{ - 11}}}), respectively. In particular, KCNQ4 encodes a voltage-gated potassium channel of the KV7 family, which is linked to neuronal excitability. The genes associated with top-ranked DMPs also included many genes involved in nervous system development, such as LIMK2 and TMOD2. Gene ontology analysis of the differentially methylated genes further identified strong enrichment of neuronal networks, including neuron projection extension, axonogenesis and neuron apoptotic process. Finally, we provided evidence that schizophrenia-associated epigenetic alterations co-localize with genetic susceptibility loci. By focusing on first-episode schizophrenia patients, our investigation lends particularly strong support for an important role of DNA methylation in schizophrenia pathogenesis unconfounded by the effects of long-term antipsychotic medication or disease progression. The observed DNA methylation aberrations in schizophrenia patients could potentially provide a valuable resource for identifying diagnostic biomarkers and developing novel therapeutic targets to benefit schizophrenia patients.

Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study

DNA Methylation in Schizophrenia: Progress and Challenges

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Genome-wide DNA methylation analysis in schizophrenia with tardive dyskinesia: a preliminary study

Methylomic Alteration in Peripheral Blood Lymphocytes of Prodromal Stage and First-Episode Chinese Han Schizophrenia Patients

Epigenome‐wide association study on methamphetamine dependence

DNA hyper-methylation associated with schizophrenia may lead to breakdown of self-tolerance

DNA Methylation Meta-Analysis Reveals Cellular Alterations in Psychosis and Markers of Treatment-Resistant Schizophrenia

Quantitative DNA Methylation Analysis of DLGAP2 Gene Using Pyrosequencing in Schizophrenia with Tardive Dyskinesia: A Linear Mixed Model Approach.

An association study between methamphetamine use disorder with psychosis and polymorphisms in MiRNA.

DNA Hyper-methylation Associated with Schizophrenia May Lead to Increased Levels of Autoantibodies

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia

Genome-Wide DNA Methylation Analysis in Male Methamphetamine Users with Different Addiction Qualities

Pyrosequencing analysis of <i>IRS1</i> methylation levels in schizophrenia with tardive dyskinesia

The DNA Methylation Profile of PLA2G4C Gene Promoter in Schizophrenia

Genetic and Epigenetic Regulation on the Transcription of GABRB2: Genotype-dependent Hydroxymethylation and Methylation Alterations in Schizophrenia.